Research ExplorerJournalsCELL REP MED Publications

CELL REP MED - Cell Reports Medicine

1 - 6 out of 6Page size: 50

Publications

  1. 2024

  2. Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis

    Poch, T., Bahn, J., Casar, C., Krause, J., Evangelakos, I., Gilladi, H., Kunzmann, L. K., Laschtowitz, A., Iuso, N., Schäfer, A-M., Liebig, L. A., Steinmann, S., Sebode, M., Folseraas, T., Engesæter, L. K., Karlsen, T. H., Franke, A., Metabolic Sciences, Max Delbrück Centre for Molecular Medicine in the Helmholtz Association, C., Schlein, C., Galun, E., Huber, S., Lohse, A. W., Gagliani, N., Schwinge, D. & Schramm, C., 16.07.2024, In: CELL REP MED. 5, 7, p. 101620

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2023

  4. CYP19A1 mediates severe SARS-CoV-2 disease outcome in males

    Stanelle-Bertram, S., Beck, S., Mounogou, N. K., Schaumburg, B., Stoll, F., Al Jawazneh, A., Schmal, Z., Bai, T., Zickler, M., Beythien, G., Becker, K., de la Roi, M., Heinrich, F., Schulz, C., Sauter, M., Krasemann, S., Lange, P., Heinemann, A., van Riel, D., Leijten, L., Bauer, L., van den Bosch, T. P. P., Lopuhaä, B., Busche, T., Wibberg, D., Schaudien, D., Goldmann, T., Lüttjohann, A., Ruschinski, J., Jania, H., Müller, Z., Pinho Dos Reis, V., Krupp-Buzimkic, V., Wolff, M., Fallerini, C., Baldassarri, M., Furini, S., Norwood, K., Käufer, C., Schützenmeister, N., von Köckritz-Blickwede, M., Schroeder, M., Jarczak, D., Nierhaus, A., Welte, T., Kluge, S., McHardy, A. C., Sommer, F., Kalinowski, J., Krauss-Etschmann, S., Richter, F., von der Thüsen, J., Baumgärtner, W., Klingel, K., Ondruschka, B., Renieri, A., Gabriel, G. & GEN-COVID Multicenter Study Group, 19.09.2023, In: CELL REP MED. 4, 9, p. 101152

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2022

  6. Remdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infection

    Heyer, A., Günther, T., Robitaille, A., Lütgehetmann, M., Addo, M. M., Jarczak, D., Kluge, S., Aepfelbacher, M., Schulze Zur Wiesch, J., Fischer, N. & Grundhoff, A., 20.09.2022, In: CELL REP MED. 3, 9, 100735.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine

    Weskamm, L. M., Fathi, A., Raadsen, M. P., Mykytyn, A. Z., Koch, T., Spohn, M., Friedrich, M., MVA-MERS-S Study Group, Haagmans, B. L., Becker, S., Sutter, G., Dahlke, C. & Addo, M. M., 19.07.2022, In: CELL REP MED. 3, 7, 100685.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19

    Schultheiß, C., Willscher, E., Paschold, L., Gottschick, C., Klee, B., Henkes, S-S., Bosurgi, L., Dutzmann, J., Sedding, D., Frese, T., Girndt, M., Höll, J., Gekle, M., Mikolajczyk, R. & Binder, M., 21.06.2022, In: CELL REP MED. 3, 6, p. 100663 100663.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2020

  10. Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes

    Tham, C. Y. L., Kah, J., Tan, A. T., Volz, T., Chia, A., Giersch, K., Ladiges, Y., Loglio, A., Borghi, M., Sureau, C., Lampertico, P., Lütgehetmann, M., Dandri-Petersen, M. & Bertoletti, A., 21.07.2020, In: CELL REP MED. 1, 4, p. 100060

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review